Cargando…
_version_ 1783289293142228992
author Tati, Swetha
Fisk, John C.
Abdullah, Julia
Karacosta, Loukia
Chrisikos, Taylor
Philbin, Padraic
Morey, Susan
Ghazal, Diala
Zalzala, Fatma
Jessee, Joseph
Quataert, Sally
Koury, Stephen
Moreno, David
Eng, Jing Ying
Glinsky, Vladislav V.
Glinskii, Olga V.
Sesay, Muctarr
Gebhard, Anthony W.
Birthare, Karamverr
Olson, James R.
Rittenhouse-Olson, Kate
author_facet Tati, Swetha
Fisk, John C.
Abdullah, Julia
Karacosta, Loukia
Chrisikos, Taylor
Philbin, Padraic
Morey, Susan
Ghazal, Diala
Zalzala, Fatma
Jessee, Joseph
Quataert, Sally
Koury, Stephen
Moreno, David
Eng, Jing Ying
Glinsky, Vladislav V.
Glinskii, Olga V.
Sesay, Muctarr
Gebhard, Anthony W.
Birthare, Karamverr
Olson, James R.
Rittenhouse-Olson, Kate
author_sort Tati, Swetha
collection PubMed
description
format Online
Article
Text
id pubmed-5747515
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Neoplasia Press
record_format MEDLINE/PubMed
spelling pubmed-57475152018-01-09 Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733] Tati, Swetha Fisk, John C. Abdullah, Julia Karacosta, Loukia Chrisikos, Taylor Philbin, Padraic Morey, Susan Ghazal, Diala Zalzala, Fatma Jessee, Joseph Quataert, Sally Koury, Stephen Moreno, David Eng, Jing Ying Glinsky, Vladislav V. Glinskii, Olga V. Sesay, Muctarr Gebhard, Anthony W. Birthare, Karamverr Olson, James R. Rittenhouse-Olson, Kate Neoplasia Corrigendum Neoplasia Press 2017-12-22 /pmc/articles/PMC5747515/ /pubmed/29277397 http://dx.doi.org/10.1016/j.neo.2017.10.001 Text en © 2017 http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Corrigendum
Tati, Swetha
Fisk, John C.
Abdullah, Julia
Karacosta, Loukia
Chrisikos, Taylor
Philbin, Padraic
Morey, Susan
Ghazal, Diala
Zalzala, Fatma
Jessee, Joseph
Quataert, Sally
Koury, Stephen
Moreno, David
Eng, Jing Ying
Glinsky, Vladislav V.
Glinskii, Olga V.
Sesay, Muctarr
Gebhard, Anthony W.
Birthare, Karamverr
Olson, James R.
Rittenhouse-Olson, Kate
Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733]
title Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733]
title_full Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733]
title_fullStr Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733]
title_full_unstemmed Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733]
title_short Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733]
title_sort corrigendum to “humanization of jaa-f11, a highly specific anti-thomsen-friedenreich pancarcinoma antibody and in vitro efficacy analysis” [neoplasia 19.9 (2017) 716-733]
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747515/
https://www.ncbi.nlm.nih.gov/pubmed/29277397
http://dx.doi.org/10.1016/j.neo.2017.10.001
work_keys_str_mv AT tatiswetha corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT fiskjohnc corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT abdullahjulia corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT karacostaloukia corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT chrisikostaylor corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT philbinpadraic corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT moreysusan corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT ghazaldiala corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT zalzalafatma corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT jesseejoseph corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT quataertsally corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT kourystephen corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT morenodavid corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT engjingying corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT glinskyvladislavv corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT glinskiiolgav corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT sesaymuctarr corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT gebhardanthonyw corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT birtharekaramverr corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT olsonjamesr corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733
AT rittenhouseolsonkate corrigendumtohumanizationofjaaf11ahighlyspecificantithomsenfriedenreichpancarcinomaantibodyandinvitroefficacyanalysisneoplasia1992017716733